___

• Akinbami LJ, JE Moorman, Liu X. Asthma prevalence,health care use, and mortality: United States, 2005-2009. Natl Health Stat Report. 2011;32:1-14.
• Beckhaus AA, Riutort MC, Castro-Rodriguez JA. Inhaled versus systemic corticosteroids for acute asthma in children. A systematic review. Pediatr Pulmonol. 2014;49:326-34.
• Bisgaard H, Hermansen MN, Loland L, Halkjaer LB, Buchvald F. Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med. 2006 11;354:1998-2005.
• Bousquet J. Primum non nocere. Prim Care Respir J. 2005;14:122-3.
• Brooks LJ, Cloutier MM, Afshani E. Significance of roentgenographic hospitalized for asthma. Chest. 1982; 82:315-8.
• Brunette MG1, Lands L, Thibodeau LP. Childhood asthma: prevention of attacks with short-term corticosteroid treatment of upper respiratory tract infection. Pediatrics. 1988;81:624-9.
• Castro-Rodriguez JA, Rodrigo GJ. Beta-agonists through metered-dose inhaler with valved holding chamber versus nebulizer for acute exacerbation of wheezing or asthma in children under 5 years of age: a systematic review with meta-analysis. J Pediatr. 2004;145:172-7.
• Cates CJ, Welsh EJ, Rowe BH. Holding chambers (spacers) versus treatment of acute asthma. Cochrane Database Syst Rev 2013. for beta-agonist
• Chen AH, Zeng GQ, Chen RC, Zhan JY, Sun LH, Huang SK, at al. Effects of nebulized high-dose budesonide exacerbation of asthma in children: a randomized, double-blind, placebo-controlled study. Respirology. 2013;18:47-52. acute
• Cheuk DK, Chau TC, Lee SL. A meta-analysis on intravenous magnesium sulphate for treating acute asthma. Arch Dis Child 2005;90:74–7.
• Connett G, Lenney W. Prevention of viral induced asthma attacks using inhaled budesonide. Arch Dis Child. 1993;68:85-7.
• Ducharme FM1, Lemire C, Noya FJ, Davis GM, Alos N, Leblond H, et all. Preemptive use of high- dose fluticasone for virus-induced wheezing in young children. N Engl J Med. 2009;360:339-53.
• Fox GF1, Marsh MJ, Milner AD.Treatment of recurrent acute wheezing episodes in infancy with oral Pediatr.1996;155:512-6. prednisolone. Eur J double-blind, placebo-controlled,
• Griffiths B, Ducharme FM. Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children. Cochrane Database Syst Rev. 2013;8:CD000060.
• Guidelines for the Diagnosis and Management of Asthma (Expert Panel Report 3) National Heart, Lung,and Blood Institute-2007.
• Horeczko T, Wintemute GJ. Asthma vital signs at triage: home or admission (ASTHmA). Pediatr Emerg Care 2013;29:175–82
• http://www.cdc.gov/nchs/FASTATS/asthma.htm [accessed 09.03.09].
• Jat KR, Chawla D. Ketamine for management of acute exacerbations of asthma in children. Cochrane Database Syst Rev. 2012;11:CD009293.
• Masoli M, Fabian D, Holt S, Beasley R; Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination 2004;59:469-78. report. Allergy.
• Mitra AAD, Bassler D, Watts K, Lasserson TJ, Ducharme FM. Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators. Cochrane Database Syst Rev. 2005;18:CD001276.
• Oommen A, Lambert PC, Grigg J. Efficacy of a short course of parent-initiated oral prednisolone for viral wheeze in children aged 1-5 years: randomised controlled trial. Lancet. 2003;362:1433-8.
• Papadopoulos NG, Arakawa H, Carlsen KH, Custovic A, Gern J, Lemanske R, at al. International consensus on (ICON) pediatric asthma. Allergy. 2012 ;67:976-97.
• Powell C, Dwan K, Milan SJ, Beasley R, Hughes R, Knopp-Sihota JA, Rowe BH. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev. 2012;12:CD003898.
• Powell C, Kolamunnage-Dona R, Lowe J, Boland A, Petrou S, Doull I, at al. MAGNETIC study group. Magnesium sulphate in acute severe asthma in children (MAGNETIC): a randomised, placebo- controlled trial. Lancet Respir Med. 2013;1:301-8.
• Qureshi F. Management of children with acute asthma in the emergency department. Pediatr Emerg Care. 1999;15:206-14.
• Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, at al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180:59-99.
• Rodrigo GJ, Rodrigo C. Continuous vs intermittent beta-agonists in the treatment of acute adult asthma: a systematic review with meta-analysis. Chest 2002; 122:160-5.
• Rodrigo GJ, Rodriquez Verde M, Peregalli V, Rodrigo C. Effects of short-term 28% and 100% oxygen on PaCO2 and peak expiratory flow rate in acute 2003;124:1312-7. trial. Chest
• Rowe BH, Bretzlaff J, Bourdon C, Bota G, Blitz S, Camargo CA. Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. 2000;CD001490. Database Syst Rev.
• Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Early emergency department treatment of acute Cochrane Database Syst Rev. 2001;CD002178.
• Simpson CR, Sheikh A. Trends in the epidemiology of asthma in England: a national study of 333,294 patients. J R Soc Med. 2010;103:98-106.
• Teoh L, Cates CJ, Hurwitz M, Acworth JP, van Asperen P, Chang AB. Anticholinergic therapy for acute asthma in children. Cochrane Database Syst Rev. 2012;4:CD003797.
• Travers AH, Milan SJ, Jones AP, Camargo CA, Jr., Rowe BH. Addition of intravenous beta (2)-agonist to inhaled beta(2)-agonists for acute asthma. Cochrane Database Syst Rev 2012; 12: CD010179.
• Vuillermin P, South M, Robertson C. Parent- initiated oral corticosteroid therapy for intermittent wheezing illnesses in children. Cochrane Database Syst Rev. 2006;19:CD005311.
• Zeiger RS, Mauger D, Bacharier LB, Guilbert TW, Martinez FD, Lemanske RF, at al. Daily or intermittent budesonide in preschool children with recurrent wheezing. N Engl J Med. 2011;365:1990- 2001.